author_facet Wang, X.
Syed, S.
Masson, E.
Walters, I. B.
Roy, A.
Wang, X.
Syed, S.
Masson, E.
Walters, I. B.
Roy, A.
author Wang, X.
Syed, S.
Masson, E.
Walters, I. B.
Roy, A.
spellingShingle Wang, X.
Syed, S.
Masson, E.
Walters, I. B.
Roy, A.
Journal of Clinical Oncology
Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
Cancer Research
Oncology
author_sort wang, x.
spelling Wang, X. Syed, S. Masson, E. Walters, I. B. Roy, A. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3095 Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors. Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2010.28.15_suppl.3095
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMC4yOC4xNV9zdXBwbC4zMDk1
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMC4yOC4xNV9zdXBwbC4zMDk1
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Society of Clinical Oncology (ASCO), 2010
imprint_str_mv American Society of Clinical Oncology (ASCO), 2010
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str wang2010characterizationofbrivanibpharmacokineticsandexposureresponseerrelationshipoffatigueinpatientswithadvancedandmetastaticsolidtumors
publishDateSort 2010
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_unstemmed Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_full Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_fullStr Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_full_unstemmed Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_short Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_sort characterization of brivanib pharmacokinetics and exposure-response (e-r): relationship of fatigue in patients with advanced and metastatic solid tumors.
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3095
publishDate 2010
physical 3095-3095
description
container_issue 15_suppl
container_start_page 3095
container_title Journal of Clinical Oncology
container_volume 28
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792320650344398861
geogr_code not assigned
last_indexed 2024-03-01T10:49:30.287Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Characterization+of+brivanib+pharmacokinetics+and+exposure-response+%28E-R%29%3A+Relationship+of+fatigue+in+patients+with+advanced+and+metastatic+solid+tumors.&rft.date=2010-05-20&genre=article&issn=1527-7755&volume=28&issue=15_suppl&spage=3095&epage=3095&pages=3095-3095&jtitle=Journal+of+Clinical+Oncology&atitle=Characterization+of+brivanib+pharmacokinetics+and+exposure-response+%28E-R%29%3A+Relationship+of+fatigue+in+patients+with+advanced+and+metastatic+solid+tumors.&aulast=Roy&aufirst=A.&rft_id=info%3Adoi%2F10.1200%2Fjco.2010.28.15_suppl.3095&rft.language%5B0%5D=eng
SOLR
_version_ 1792320650344398861
author Wang, X., Syed, S., Masson, E., Walters, I. B., Roy, A.
author_facet Wang, X., Syed, S., Masson, E., Walters, I. B., Roy, A., Wang, X., Syed, S., Masson, E., Walters, I. B., Roy, A.
author_sort wang, x.
container_issue 15_suppl
container_start_page 3095
container_title Journal of Clinical Oncology
container_volume 28
description
doi_str_mv 10.1200/jco.2010.28.15_suppl.3095
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMC4yOC4xNV9zdXBwbC4zMDk1
imprint American Society of Clinical Oncology (ASCO), 2010
imprint_str_mv American Society of Clinical Oncology (ASCO), 2010
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T10:49:30.287Z
match_str wang2010characterizationofbrivanibpharmacokineticsandexposureresponseerrelationshipoffatigueinpatientswithadvancedandmetastaticsolidtumors
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 3095-3095
publishDate 2010
publishDateSort 2010
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Wang, X. Syed, S. Masson, E. Walters, I. B. Roy, A. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3095 Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors. Journal of Clinical Oncology
spellingShingle Wang, X., Syed, S., Masson, E., Walters, I. B., Roy, A., Journal of Clinical Oncology, Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors., Cancer Research, Oncology
title Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_full Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_fullStr Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_full_unstemmed Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_short Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
title_sort characterization of brivanib pharmacokinetics and exposure-response (e-r): relationship of fatigue in patients with advanced and metastatic solid tumors.
title_unstemmed Characterization of brivanib pharmacokinetics and exposure-response (E-R): Relationship of fatigue in patients with advanced and metastatic solid tumors.
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3095